Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ; CREDO Investigators, Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy fol- lowing percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411 2420. 34. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S; Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation. 2004;110:1202 1208. doi: 10.1161/01.CIR.0000140675.85342.1B. 35. Kim DH, Daskalakis C, Silvestry SC, Sheth MP, Lee AN, Adams S, Hohmann S, Medvedev S, Whellan DJ. Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2009;138:1377 1384. doi: 10.1016/j.jtcvs.2009.07.027. 36. S rensen R, Abildstr m SZ, Hansen PR, Hvelplund A, Andersson C, Charlot M, Fosb l EL, K ber L, Madsen JK, Gislason GH, Torp-Pedersen C. Efficacy of post-operative clopidogrel treatment in patients revascular- ized with coronary artery bypass grafting after myocardial infarction. J Am Coll Cardiol. 2011;57:1202 1209. doi: 10.1016/j.jacc.2010.09.069. 37. Gao C, Ren C, Li D, Li L. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting. Ann Thorac Surg. 2009;88:59 62. doi: 10.1016/j.athoracsur.2009.04.024. H, Khan O, Masood I, Large S. Clopidogrel did not inhibit platelet function early after coronary bypass surgery: a prospective randomized trial. J Thorac Cardiovasc Surg. 2004;128:432 435. doi: 10.1016/j.jtcvs.2004.03.007. 39. David JL, Limet R. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients. Thromb Haemost. 1999;82:1417 1421. 40. 